Completed NA INTERVENTIONAL 2-arm NCT05429580

Prophylactic Tranexamic Acid Use After Vaginal Delivery

Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomised, Double-blind, Placebo-controlled Trial

Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital

Conditions Postpartum Hemorrhage Prophylactic Tranexamic Acid Use Vaginal Delivery

Interventions 5% Dextrose Tranexamic acid

Updated 5 times since 2022 Last updated: Dec 1, 2023 Started: Sep 1, 2021 Primary completion: Feb 28, 2022 Completion: Feb 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Postpartum Hemorrhage and Prophylactic Tranexamic Acid Use and is currently completed. Sanliurfa Mehmet Akif Inan Education and Research Hospital leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2024 — Jul 2024 [monthly]

Completed NA
Jul 2022 — Jan 2024 [monthly]

Completed NA

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanliurfa Mehmet Akif Inan Education and Research Hospital
Sisli Hamidiye Etfal Training and Research Hospital

Data source: Sanliurfa Mehmet Akif Inan Education and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bursa, Turkey (Türkiye)